{"id":7048,"date":"2013-05-30T05:52:47","date_gmt":"2013-05-30T09:52:47","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=7048"},"modified":"2013-05-30T05:52:47","modified_gmt":"2013-05-30T09:52:47","slug":"aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048","title":{"rendered":"Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) shares increased by 14.06%"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 05\/30\/2013 (wallstreetpr) &#8211;\u00a0The share prices of Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) had surged by 14.06 percent to close at $69.28 per share for the end of last trading session. The shares of the pharmaceutical company had been trading in the range of $63.68 to $71.82 per share during the day before closing at $8.54 per share increase over the previous day\u2019s closing price.<\/p>\n<p style=\"text-align: justify;\">Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) is a bio pharmaceutical company involved in the development and commercialization of treatment therapies for lipid disorders. The company had recently developed its first product candidate which is used as an oral once a day treatment for patients with inherited lipid disorders. The first product candidate of Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) named lomitapide was developed for the treatment of homozygous familial hypercholesterolemia.<\/p>\n<p style=\"text-align: justify;\">The drug for treatment of inherited lipid disorder developed by Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) was further given orphan drug designation by the Food and Drugs Administration of the United States in 2011.<\/p>\n<p style=\"text-align: justify;\">The recent increase in share prices of the drug development company had resulted in Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) touching new levels of high prices in 52 weeks. The shares of the pharmaceutical company had thereby recorded new 52 week high price level at $71.82 per share at the close of last trading session while the 52 week low price level is at $12.86 per share. Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) presently holds 28.81 million shares outstanding in the market with an institutional ownership of 108 percent of its holdings.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 05\/30\/2013 (wallstreetpr) &#8211;\u00a0The share prices of Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) had surged by 14.06 percent to close at $69.28 per share for the [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":7049,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[2375,2376],"stock_ticker":[],"class_list":["post-7048","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-aegerion-pharmaceuticals-inc-nasdaqaegr","tag-nasdaqaegr","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) shares increased by 14.06% - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) shares increased by 14.06% - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 05\/30\/2013 (wallstreetpr) &#8211;\u00a0The share prices of Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) had surged by 14.06 percent to close at $69.28 per share for the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-05-30T09:52:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/vitaminas-1024.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lisa Ray\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lisa Ray\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048\"},\"author\":{\"name\":\"Lisa Ray\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c\"},\"headline\":\"Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) shares increased by 14.06%\",\"datePublished\":\"2013-05-30T09:52:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048\"},\"wordCount\":252,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/vitaminas-1024.jpg\",\"keywords\":[\"Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR)\",\"NASDAQ:AEGR\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048\",\"name\":\"Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) shares increased by 14.06% - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/vitaminas-1024.jpg\",\"datePublished\":\"2013-05-30T09:52:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/vitaminas-1024.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/vitaminas-1024.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) shares increased by 14.06%\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c\",\"name\":\"Lisa Ray\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png\",\"caption\":\"Lisa Ray\"},\"description\":\"Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/linsay-thomas\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) shares increased by 14.06% - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048","og_locale":"en_US","og_type":"article","og_title":"Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) shares increased by 14.06% - Wall Street PR","og_description":"Boston, MA 05\/30\/2013 (wallstreetpr) &#8211;\u00a0The share prices of Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) had surged by 14.06 percent to close at $69.28 per share for the [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2013-05-30T09:52:47+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/vitaminas-1024.jpg","type":"image\/jpeg"}],"author":"Lisa Ray","twitter_misc":{"Written by":"Lisa Ray","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048"},"author":{"name":"Lisa Ray","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c"},"headline":"Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) shares increased by 14.06%","datePublished":"2013-05-30T09:52:47+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048"},"wordCount":252,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/vitaminas-1024.jpg","keywords":["Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR)","NASDAQ:AEGR"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048","url":"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048","name":"Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) shares increased by 14.06% - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/vitaminas-1024.jpg","datePublished":"2013-05-30T09:52:47+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/vitaminas-1024.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/vitaminas-1024.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/aegerion-pharmaceuticals-inc-nasdaqaegr-shares-increased-by-14-06-7048#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) shares increased by 14.06%"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c","name":"Lisa Ray","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png","caption":"Lisa Ray"},"description":"Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/linsay-thomas"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/7048","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=7048"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/7048\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/7049"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=7048"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=7048"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=7048"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=7048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}